No insider purchase over the last 90 days. The latest, by 최석근, was filed 03 Aug 2026.
Who traded when
BuySale+1 other insider
Since the insiders bought
- +8.4%Entry ₩1,561 · Close 04 Nov 2026 ₩1,692
- +13.9%Entry ₩1,485 · Close 04 Nov 2026 ₩1,692
- +13.9%Entry ₩1,485 · Close 04 Nov 2026 ₩1,692
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 127,989 sharesShareKRXDART:20260803000065Canonical exit: 1 Nov 2026 (T+90)
- 135,244 sharesShareKRXDART:20260622000215Canonical exit: 20 Sept 2026 (T+90)
- 59,737 sharesKRXDART:20260515001193Canonical exit: 6 Aug 2026 (T+90)
- 324,270 sharesKRXDART:20260507000779Canonical exit: 27 Jul 2026 (T+90)
- ●Executives0DART
- 39,000 sharesShareKRXDART:20260313000224Canonical exit: 9 Jun 2026 (T+90)
- 72,268 sharesShareKRXDART:20260313000195Canonical exit: 4 Jun 2026 (T+90)
- 200,000 sharesShareKRXDART:20260225005258Canonical exit: 26 May 2026 (T+90)
- 528,320 sharesShareKRXDART:20251217000597
- 7,402 sharesShareKRXDART:20251217000598
- 2,675 sharesShareKRXDART:20251217000599Canonical exit: 18 Mar 2026 (T+90)
- 727,951 sharesShareKRXDART:20251217000600Canonical exit: 18 Mar 2026 (T+90)
- 4,736,033 sharesKRXDART:20251217000585Canonical exit: 10 Mar 2026 (T+90)
- 13,678 sharesShareKRXDART:20251217000595Canonical exit: 17 Mar 2026 (T+90)
- 539 sharesShareKRXDART:20251217000593Canonical exit: 17 Mar 2026 (T+90)
- ShareKRXDART:20251217000596
- 2,697 sharesShareKRXDART:20251106000339Canonical exit: 4 Feb 2026 (T+90)
- 38,380 sharesShareKRXDART:20251106000322Canonical exit: 4 Feb 2026 (T+90)
- 779,906 sharesShareKRXDART:20251106000286Canonical exit: 4 Feb 2026 (T+90)
- 7,246 sharesShareKRXDART:20251106000258Canonical exit: 4 Feb 2026 (T+90)
- 194,350 sharesShareKRXDART:20251106000271Canonical exit: 4 Feb 2026 (T+90)
- 13,378 sharesShareKRXDART:20251106000326Canonical exit: 4 Feb 2026 (T+90)
- 3,480,133 sharesShareKRXDART:20251106000333Canonical exit: 4 Feb 2026 (T+90)
25 of 74 declarations
About EyeGene Inc.
On November 6, 2025, 7 insiders of 아이진 (EyeGene Inc.) bought on the same day. The South Korean health care company, valued at KRW 84.2 billion and 29.6% held by insiders, saw 18 filings that year, after 30 in 2021, 6 in both 2022 and 2023, 4 in 2024 and 8 in 2026.
최석근, filed as 대표이사, filed 26 of the 72 filings, 5 of them purchases. 한국비엠아이 signs 25, all purchases, 우구 (사실상지배주주) 5, including 4 purchases, and 이광인 3 purchases. The company 아이진 files 7. In all, 41 purchases, 2 sales and 29 filings of another kind, published from May 10, 2021 to August 3, 2026. No amount is reported.
Read moreShow less
Over the last twelve months, 23 filings, including 19 purchases and 2 sales. For 27 purchases a 90-day result is stored: a median of minus 6.4%, 37% positive, figures from the past, not a forecast. The publication delay is 7 days at the median.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
